Literature DB >> 30902519

Scope and Epidemiology of Gynecologic Cancers: An Overview.

Leah R C Ledford1, Suzy Lockwood2.   

Abstract

OBJECTIVE: To provide a current overview of the scope and epidemiology of gynecologic cancers. DATA SOURCES: A review of articles dated 2005-2018 from PubMed, as well as data from The Centers for Disease Control and Prevention, National Cervical Cancer Coalition, and the American Cancer Society.
CONCLUSION: Gynecologic cancers include any cancer that originates in a woman's reproductive system; cervical, ovarian, uterine, vaginal, vulvar, and fallopian tube (which is very rare), each named for the body part in which the cancer commences. The overall incidence of these cancers has decreased with time, except for vulvar and endometrial cancers, but racial disparities still exist. IMPLICATIONS FOR NURSING PRACTICE: Nurses play a significant role in educating patients on the importance of preventative measures and modifiable lifestyles and behaviors. Likewise, nurses are in a unique position to help coordinate patients' care, thereby improving patient satisfaction. Nurses can participate and contribute to gynecologic research and influence political change to benefit those affected by gynecologic cancers.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cervical cancer; financial burden; gynecologic cancer; ovarian cancer; uterine cancer; vaginal cancer; vulvar cancer

Mesh:

Year:  2019        PMID: 30902519     DOI: 10.1016/j.soncn.2019.03.002

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  11 in total

Review 1.  Pre-treatment sarcopenic assessments as a prognostic factor for gynaecology cancer outcomes: systematic review and meta-analysis.

Authors:  E H Sutton; M Plyta; K Fragkos; S Di Caro
Journal:  Eur J Clin Nutr       Date:  2022-02-22       Impact factor: 4.016

Review 2.  Perioperative enhanced recovery programmes for women with gynaecological cancers.

Authors:  Janita Pak Chun Chau; Xu Liu; Suzanne Hoi Shan Lo; Wai Tong Chien; Sze Ki Hui; Kai Chow Choi; Jie Zhao
Journal:  Cochrane Database Syst Rev       Date:  2022-03-15

Review 3.  The Interplay between Cancer Biology and the Endocannabinoid System-Significance for Cancer Risk, Prognosis and Response to Treatment.

Authors:  Estefanía Moreno; Milena Cavic; Ana Krivokuca; Enric I Canela
Journal:  Cancers (Basel)       Date:  2020-11-05       Impact factor: 6.639

Review 4.  Phytochemicals in Gynecological Cancer Prevention.

Authors:  Marta Woźniak; Rafał Krajewski; Sebastian Makuch; Siddarth Agrawal
Journal:  Int J Mol Sci       Date:  2021-01-26       Impact factor: 5.923

5.  A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma.

Authors:  Haoya Xu; Ruoyao Zou; Jiyu Liu; Liancheng Zhu
Journal:  J Oncol       Date:  2021-03-06       Impact factor: 4.375

6.  Utilization of a 3-D tissue engineered model to investigate the effects of perfusion on gynecologic cancer biology.

Authors:  Alba Martinez; Molly S Buckley; Carly B Scalise; Dezhi Wang; Ashwini A Katre; Michael J Birrer; Joel L Berry; Rebecca C Arend
Journal:  J Tissue Eng       Date:  2021-11-17       Impact factor: 7.940

Review 7.  Natural Bioactives: Back to the Future in the Fight against Human Papillomavirus? A Narrative Review.

Authors:  Silvia Massa; Riccardo Pagliarello; Francesca Paolini; Aldo Venuti
Journal:  J Clin Med       Date:  2022-03-07       Impact factor: 4.241

8.  New Analytical Approach for the Alignment of Different HE4 Automated Immunometric Systems: An Italian Multicentric Study.

Authors:  Antonio Angeloni; Corrado De Vito; Antonella Farina; Daniela Terracciano; Michele Cennamo; Rita Passerini; Fabio Bottari; Annalisa Schirinzi; Roberto Vettori; Agostino Steffan; Valerio Mais; Ferdinando Coghe; Luigi Della Corte; Giuseppe Bifulco; Valentina Baccolini; Elena Berardelli; Giuseppe Migliara; Emanuela Anastasi
Journal:  J Clin Med       Date:  2022-04-02       Impact factor: 4.241

Review 9.  Tumor Budding in Gynecologic Cancer as a Marker for Poor Survival: A Systematic Review and Meta-Analysis of the Perspectives of Epithelial-Mesenchymal Transition.

Authors:  Muhammad Joan Ailia; Nishant Thakur; Yosep Chong; Kwangil Yim
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

10.  The miR-133b/brefeldin A-inhibited guanine nucleotide-exchange protein 1 (ARFGEF1) axis represses proliferation, invasion, and migration in cervical cancer cells.

Authors:  Lingling Jiang; Xuexin Wang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.